Clinical Trial Update: Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of E7777 for relapsed or refractory diffuse large B-cell lymphoma is suspended; no results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• High-grade B-cell Lymphoma

Drugs mentioned

• E7777 (E7777)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: DLBCL, Diffuse Large B Cell Lymphoma | Phase 1, Phase 2 | Status: SUSPENDED